Loading clinical trials...
Loading clinical trials...
Evaluation of Physiological and Psychological Factors Involved in Exercise Intolerance in Patients With Transfusion-dependent β-thalassemia
Conditions
Interventions
Maximal incremental exercise test
Locations
1
France
CH Métropole Savoie
Chambéry, France
Start Date
September 4, 2025
Primary Completion Date
October 1, 2028
Completion Date
October 1, 2028
Last Updated
October 6, 2025
Lead Sponsor
Centre Hospitalier Metropole Savoie
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions